Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance - Nash, P; Mease, PJ; Fleishaker, D; Wu, J; Coates, LC; Behrens, F; Gladman, DD; Kivitz, AJ; Wei, JC; Shirinsky, I; Menon, S; Romero, AB; et al. (Lancet Rheumatology, 2020)